Bio-Techne Corp
TECH
Market Cap$9.78B
Close$
$39.60
37.7% downside
Current Fair Value
37.7% downsideOvervalued by 37.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.78 Billion |
|---|---|
| Enterprise Value | $10.09 Billion |
| Dividend Yield | $0.3189 (0.51%) |
| Earnings per Share | $1.39 |
| Beta | 1.01 |
| Outstanding Shares | 157,191,685 |
| Avg 30 Day Volume | 992,614 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 43.63 |
|---|---|
| PEG | -96.81 |
| Price to Sales | 9.07 |
| Price to Book Ratio | 5.29 |
| Enterprise Value to Revenue | 8.81 |
| Enterprise Value to EBIT | 38.33 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
ESG Score
No data
About Bio-Techne Corp
2,100 employees
CEO: Charles Kummeth Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems , No...